expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology Today
qolumnistRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)TRT WorldVečer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesLazar BermanJafar Bedru GeletuNava FreibergStav Levaton
Gideon Levy
Belen Fernandez
Tafi MhakaThe Asahi ShimbunReutersCharlie SummersJessica SteinbergSam SokolZev StubJasim Al-AzzawiRossella Tercatin
Tarik Cyril Amar
Somdeep SenJeremy SharonGrace GilsonNurit YohananSharon WrobelLuke Tress
John NostaAbdulla MoaswesAhmad Abushawish
Samer JaberIsaac KaledziAndrea Teti
Moncef Khane
Ghada AgeelDonya Abu SittaEsther FeldenAyman SobhThe Japan News EditorialDavid Horovitz
Sabine KinkartzAriela Karmel
Marcel FürstenauRicardo Martins
Sabine Sterk
Yara Hawari
Andrew Silow-CarrollJulian RyallIbrahim AbusharifFuad Abu SaifSalah Uddin Shoaib Choudhury
|
 |
Some popular weight loss drugs may lower the risk of dementia and stroke for patients with Type 2 diabetes and obesity, new research published in JAMA Network suggests.
Patients taking © The Hill
visit website 
login
who are we?
contact us
qosheapp
